KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $70.2 million.

  • Idexx Laboratories' Tax Provisions rose 619.51% to $70.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $246.2 million, marking a year-over-year increase of 850.52%. This contributed to the annual value of $222.0 million for FY2024, which is 269.74% up from last year.
  • Idexx Laboratories' Tax Provisions amounted to $70.2 million in Q3 2025, which was up 619.51% from $68.4 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Tax Provisions ranged from a high of $70.2 million in Q3 2025 and a low of $29.1 million during Q4 2021
  • Its 5-year average for Tax Provisions is $51.7 million, with a median of $53.2 million in 2022.
  • Per our database at Business Quant, Idexx Laboratories' Tax Provisions skyrocketed by 107481.84% in 2021 and then crashed by 2039.9% in 2022.
  • Over the past 5 years, Idexx Laboratories' Tax Provisions (Quarter) stood at $29.1 million in 2021, then surged by 40.86% to $41.0 million in 2022, then grew by 10.09% to $45.1 million in 2023, then fell by 10.87% to $40.2 million in 2024, then soared by 74.37% to $70.2 million in 2025.
  • Its last three reported values are $70.2 million in Q3 2025, $68.4 million for Q2 2025, and $67.4 million during Q1 2025.